South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to jointly research and develop new drug candidates for the treatment of depression.Neurorive is a company that focuses on central nervous system diseas
Daewoong's new GERD drug Fexuclue South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fexuclue (active ingredient: Fexuprazan).The company said on Wednesday that it has submitted new drug applications (
Daewoong Pharmaceutical's office building DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight year for the company to release a self-developed medication following last year's Fexuclue, which treats ga
Daewoong Pharmaceutical's botox product Nabota South Korea’s Daewoong Pharmaceutical Co. has obtained approval for the sale of its botulinum toxin product, Nabota, in Saudi Arabia and Ukraine.Saudi Arabia, one of the largest markets for botulinum toxin, more commonly known as botox, in th